Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04502706
Title Study of FSI-189 as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications

marginal zone B-cell lymphoma

B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

FSI-189

FSI-189 + Rituximab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35233 United States Details
City of Hope Duarte California 91010 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field